ANI Partners With Oakrum For First US Generic Of Cystadane
Partners Receive 180-Days Of CGT Exclusivity For Betaine Anhydrous Powder
ANI Pharmaceuticals has partnered with Oakrum Pharma to launch a generic version of Cystadane (betaine anhydrous) powder for oral solution after receiving FDA approval with Competitive Generic Therapy status and 180 days of associated exclusivity.
